Login Register
English
0

Cart

$ 0

The Bcr-Abl inhibitor DCC-2036 inhibits necroptosis and ameliorates osteoarthritis by targeting RIPK1 and RIPK3 kinases(KTB1410-7.5)

Date:2023-09-19 Views:87